A citation-based method for searching scientific literature

Andrea Katharina Lindner, Gert Schachtner, Gennadi Tulchiner, Martin Thurnher, Gerold Untergasser, Peter Obrist, Iris Pipp, Fabian Steinkohl, Wolfgang Horninger, Zoran Culig, Renate Pichler. Int J Mol Sci 2021
Times Cited: 4







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
C R Boland, S N Thibodeau, S R Hamilton, D Sidransky, J R Eshleman, R W Burt, S J Meltzer, M A Rodriguez-Bigas, R Fodde, G N Ranzani,[...]. Cancer Res 1998
75

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
50

Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms.
Ibrahim Halil Sahin, Mehmet Akce, Olatunji Alese, Walid Shaib, Gregory B Lesinski, Bassel El-Rayes, Christina Wu. Br J Cancer 2019
101
50

Cytoplasmic MSH2 Related to Genomic Deletions in the MSH2/EPCAM Genes in Colorectal Cancer Patients With Suspected Lynch Syndrome.
Lin Dong, Shuangmei Zou, Xianglan Jin, Haizhen Lu, Ye Zhang, Lei Guo, Jianqiang Cai, Jianming Ying. Front Oncol 2021
4
50

Microsatellite Instability as a Biomarker for PD-1 Blockade.
Jonathan C Dudley, Ming-Tseh Lin, Dung T Le, James R Eshleman. Clin Cancer Res 2016
461
50

A molecular portrait of microsatellite instability across multiple cancers.
Isidro Cortes-Ciriano, Sejoon Lee, Woong-Yang Park, Tae-Min Kim, Peter J Park. Nat Commun 2017
271
50

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
50

Computational Prediction and Validation of Tumor-Associated Neoantigens.
Vladimir Roudko, Benjamin Greenbaum, Nina Bhardwaj. Front Immunol 2020
31
25

Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.
Rajarsi Mandal, Robert M Samstein, Ken-Wing Lee, Jonathan J Havel, Hao Wang, Chirag Krishna, Erich Y Sabio, Vladimir Makarov, Fengshen Kuo, Pedro Blecua,[...]. Science 2019
230
25

Microsatellite instability differences between familial and sporadic ovarian cancers.
I I Arzimanoglou, T Lallas, M Osborne, H Barber, F Gilbert. Carcinogenesis 1996
62
25

Remarkable selective constraints on exonic dinucleotide repeats.
Ryan J Haasl, Bret A Payseur. Evolution 2014
5
25

Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High.
Sumit Middha, Rona Yaeger, Jinru Shia, Zsofia K Stadler, Sarah King, Shanna Guercio, Victoriya Paroder, David D B Bates, Satshil Rana, Luis A Diaz,[...]. JCO Precis Oncol 2019
48
25


The Immune Biology of Microsatellite-Unstable Cancer.
Matthias Kloor, Magnus von Knebel Doeberitz. Trends Cancer 2016
111
25

Towards a vaccine to prevent cancer in Lynch syndrome patients.
Magnus von Knebel Doeberitz, Matthias Kloor. Fam Cancer 2013
42
25

Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
Matthias Kloor, Cathrin Huth, Anita Y Voigt, Axel Benner, Peter Schirmacher, Magnus von Knebel Doeberitz, Hendrik Bläker. Lancet Oncol 2012
90
25


Proteogenomic Characterization of Endometrial Carcinoma.
Yongchao Dou, Emily A Kawaler, Daniel Cui Zhou, Marina A Gritsenko, Chen Huang, Lili Blumenberg, Alla Karpova, Vladislav A Petyuk, Sara R Savage, Shankha Satpathy,[...]. Cell 2020
125
25


Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.
Vito Amodio, Gianluca Mauri, Nicole M Reilly, Andrea Sartore-Bianchi, Salvatore Siena, Alberto Bardelli, Giovanni Germano. Cancers (Basel) 2021
12
25

Immune Activation in Mismatch Repair-Deficient Carcinogenesis: More Than Just Mutational Rate.
Jason A Willis, Laura Reyes-Uribe, Kyle Chang, Steven M Lipkin, Eduardo Vilar. Clin Cancer Res 2020
31
25

Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens.
Sandra Wagner, Christina S Mullins, Michael Linnebacher. World J Gastroenterol 2018
44
25

Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family.
Ciyu Yang, Margaret Sheehan, Ester Borras, Karen Cadoo, Kenneth Offit, Liying Zhang. Fam Cancer 2020
1
100


Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.
Minsuk Kwon, Minae An, Samuel J Klempner, Hyuk Lee, Kyoung-Mee Kim, Jason K Sa, Hee Jin Cho, Jung Yong Hong, Taehyang Lee, Yang Won Min,[...]. Cancer Discov 2021
28
25

The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol.
Neil A J Ryan, Dominic Blake, Marcus Cabrera-Dandy, Mark A Glaire, D Gareth Evans, Emma J Crosbie. Syst Rev 2018
12
25

RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors.
Jordan L Kohlmeyer, Courtney A Kaemmer, Casey Pulliam, Chandra K Maharjan, Allison Moreno Samayoa, Heather J Major, Kendall E Cornick, Vickie Knepper-Adrian, Rajesh Khanna, Jessica C Sieren,[...]. Clin Cancer Res 2020
21
25



MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway.
Junhong Guan, Changzheng Lu, Qihuang Jin, Huiming Lu, Xiang Chen, Lei Tian, Yanbin Zhang, Janice Ortega, Junqiu Zhang, Silvia Siteni,[...]. Cancer Cell 2021
42
25

Genetic basis for clinical response to CTLA-4 blockade in melanoma.
Alexandra Snyder, Vladimir Makarov, Taha Merghoub, Jianda Yuan, Jesse M Zaretsky, Alexis Desrichard, Logan A Walsh, Michael A Postow, Phillip Wong, Teresa S Ho,[...]. N Engl J Med 2014
25

The clinical utility of microsatellite instability in colorectal cancer.
Zhenli Diao, Yanxi Han, Yuqing Chen, Rui Zhang, Jinming Li. Crit Rev Oncol Hematol 2021
9
25

Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer.
Frank M Speetjens, Marjolein M Lauwen, Kees L Franken, Connie M Janssen-van Rhijn, Suzanne van Duikeren, Sandra A Bres, Cornelis J H van de Velde, Cornelis J M Melief, Peter J K Kuppen, Sjoerd H van der Burg,[...]. Int J Cancer 2008
25
25

A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells.
I Saeterdal, M K Gjertsen, P Straten, J A Eriksen, G Gaudernack. Cancer Immunol Immunother 2001
61
25

Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.
Patrick M Boland, Matthew B Yurgelun, C Richard Boland. CA Cancer J Clin 2018
70
25

Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.
Johannes Gebert, Ozkan Gelincik, Mine Oezcan-Wahlbrink, Jason D Marshall, Alejandro Hernandez-Sanchez, Katharina Urban, Mark Long, Eduardo Cortes, Elena Tosti, Eva-Maria Katzenmaier,[...]. Gastroenterology 2021
10
25

Genetic and non-genetic clonal diversity in cancer evolution.
James R M Black, Nicholas McGranahan. Nat Rev Cancer 2021
39
25

High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers.
Maribel González-Acosta, Fátima Marín, Benjamin Puliafito, Nuria Bonifaci, Anna Fernández, Matilde Navarro, Hector Salvador, Francesc Balaguer, Silvia Iglesias, Angela Velasco,[...]. J Med Genet 2020
10
25

Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.
M L Veigl, L Kasturi, J Olechnowicz, A H Ma, J D Lutterbaugh, S Periyasamy, G M Li, J Drummond, P L Modrich, W D Sedwick,[...]. Proc Natl Acad Sci U S A 1998
510
25


A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial.
Matthias Kloor, Miriam Reuschenbach, Claudia Pauligk, Julia Karbach, Mohammad-Reza Rafiyan, Salah-Eddin Al-Batran, Mirjam Tariverdian, Elke Jäger, Magnus von Knebel Doeberitz. Clin Cancer Res 2020
28
25

Lynch Syndrome: From Screening to Diagnosis to Treatment in the Era of Modern Molecular Oncology.
Stacey A Cohen, Colin C Pritchard, Gail P Jarvik. Annu Rev Genomics Hum Genet 2019
21
25

Analysis of somatic microsatellite indels identifies driver events in human tumors.
Yosef E Maruvka, Kent W Mouw, Rosa Karlic, Prasanna Parasuraman, Atanas Kamburov, Paz Polak, Nicholas J Haradhvala, Julian M Hess, Esther Rheinbay, Yehuda Brody,[...]. Nat Biotechnol 2017
73
25


Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.
Eliezer M Van Allen, Diana Miao, Bastian Schilling, Sachet A Shukla, Christian Blank, Lisa Zimmer, Antje Sucker, Uwe Hillen, Marnix H Geukes Foppen, Simone M Goldinger,[...]. Science 2015
25

Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response.
Meagan Montesion, Karthikeyan Murugesan, Dexter X Jin, Radwa Sharaf, Nora Sanchez, Ameet Guria, Max Minker, Gerald Li, Virginia Fisher, Ethan S Sokol,[...]. Cancer Discov 2021
44
25

Microsatellite instability in endometrial cancer: New purpose for an old test.
Katherine C Kurnit, Shannon N Westin, Robert L Coleman. Cancer 2019
8
25


A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families.
A Stella, A Wagner, K Shito, S M Lipkin, P Watson, G Guanti, H T Lynch, R Fodde, B Liu. Cancer Res 2001
32
25

The Spectrum of Benefit from Checkpoint Blockade in Hypermutated Tumors.
Benoit Rousseau, Michael B Foote, Steven B Maron, Bill H Diplas, Steve Lu, Guillem Argilés, Andrea Cercek, Luis A Diaz. N Engl J Med 2021
50
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.